Hancock Jaffe Laboratories Inc EV/EBIT
What is the EV/EBIT of Hancock Jaffe Laboratories Inc?
The EV/EBIT of Hancock Jaffe Laboratories Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with ev/ebit similar to Hancock Jaffe Laboratories Inc
- Chesapeake has EV/EBIT of N/A
- Dynatronics has EV/EBIT of N/A
- North Peak Resources has EV/EBIT of N/A
- Angiodynamic Inc has EV/EBIT of N/A
- TGB Banquets and Hotels has EV/EBIT of N/A
- Enviroleach Technologies has EV/EBIT of N/A
- Hancock Jaffe Laboratories Inc has EV/EBIT of N/A
- Atyr Pharma Inc has EV/EBIT of N/A
- SCWorx Corp has EV/EBIT of N/A
- Solid Biosciences Inc has EV/EBIT of N/A
- Meteorite Capital has EV/EBIT of N/A
- Simran Farms has EV/EBIT of N/A
- Comscore has EV/EBIT of N/A